ZEVRA THERAPEUTICS INC (ZVRA) Stock Analyst Earnings Estimates
NASDAQ:ZVRA - Nasdaq - US4884452065 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 10.46M -63.49% | 27.461M 162.53% | 23.612M -14.02% | 95.156M 303.00% | 169.05M 77.66% | 251.59M 48.83% | 331.54M 31.78% | 378.3M 14.10% | 437.99M 15.78% | 473.83M 8.18% | 556.92M 17.54% | |
| EBITDA YoY % growth | -23.91M -399.25% | -48.598M -103.25% | -80.614M -65.88% | -10.404M 87.09% | 7.854M 175.49% | 69.462M 784.42% | 136.58M 96.63% | 197.88M 44.88% | 499.19M 152.27% | 635.46M 27.30% | N/A | |
| EBIT YoY % growth | -24.85M -421.47% | -49.604M -99.61% | -87.003M -75.40% | -15.703M 81.95% | 45.087M 387.12% | 127.53M 182.85% | 192.91M 51.27% | 233.75M 21.17% | 284.43M 21.68% | 313.82M 10.33% | 379.65M 20.98% | |
| Operating Margin | -237.57% | -180.63% | -368.47% | -16.50% | 26.67% | 50.69% | 58.19% | 61.79% | 64.94% | 66.23% | 68.17% | |
| EPS YoY % growth | -0.69 -50.00% | -1.29 -86.96% | -2.26 -75.19% | 0.96 142.27% | 0.67 -30.19% | 1.77 165.28% | 2.77 56.61% | 3.31 19.59% | 4.03 21.77% | 4.12 2.21% | 5.02 21.71% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.53 418.29% | -0.07 90.26% | -0.05 92.38% | 0.09 247.34% | 0.16 -89.32% | 0.14 312.51% | 0.19 468.43% |
| Revenue Q2Q % growth | 22.986M 416.66% | 24.803M 571.26% | 26.717M 121.85% | 37.536M 83.99% | 44.414M 93.22% | 47.044M 89.67% | 48.816M 82.72% |
| EBITDA Q2Q % growth | -2.652M 87.17% | -2.142M 90.51% | -1.53M 83.05% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -4.482M 81.16% | -2.858M 89.53% | -2.15M 86.05% | 10.898M 303.25% | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -0.06 85.00% | -0.19 | 0.13 | 68.49% |
| Q4 2024 Q2Q % growth | -0.69 -72.50% | -0.41 | -0.28 | -67.34% |
| Q3 2024 Q2Q % growth | -0.69 -72.50% | -0.43 | -0.26 | -60.59% |
| Q2 2024 Q2Q % growth | -0.48 -220.00% | -0.44 | -0.04 | -8.43% |
| Q1 2024 Q2Q % growth | -0.40 -17.65% | -0.49 | 0.09 | 17.96% |
| Q4 2023 Q2Q % growth | -0.40 -53.85% | -0.27 | -0.13 | -46.15% |
| Q3 2023 Q2Q % growth | -0.40 -110.53% | -0.30 | -0.10 | -31.82% |
| Q2 2023 Q2Q % growth | -0.15 21.05% | -0.35 | 0.20 | 57.17% |
| Q1 2023 Q2Q % growth | -0.34 -580.00% | -0.24 | -0.10 | -43.37% |
| Q4 2022 Q2Q % growth | -0.26 -225.00% | -0.18 | -0.08 | -47.06% |
| Q3 2022 Q2Q % growth | -0.19 -280.00% | -0.13 | -0.06 | -43.29% |
| Q2 2022 Q2Q % growth | -0.19 -190.48% | -0.12 | -0.07 | -55.23% |
| Q1 2022 Q2Q % growth | -0.05 90.74% | -0.06 | 0.01 | 10.87% |
| Q4 2021 Q2Q % growth | -0.08 92.52% | -0.08 | 0.00 | -4.58% |
| Q3 2021 Q2Q % growth | -0.05 92.19% | -0.08 | 0.03 | 34.64% |
| Q2 2021 Q2Q % growth | 0.21 31.25% | 0.23 | -0.02 | -8.50% |
| Q1 2021 Q2Q % growth | -0.54 69.32% | -0.17 | -0.37 | -211.42% |
| Q4 2020 Q2Q % growth | -1.07 -568.75% | -0.65 | -0.42 | -63.91% |
| Q3 2020 Q2Q % growth | -0.64 -166.67% | -0.82 | 0.18 | 21.57% |
| Q2 2020 Q2Q % growth | 0.16 103.03% | 0.00 | 0.16 | % |
| Q1 2020 Q2Q % growth | -1.76 76.09% | 0.16 | -1.92 | -1,178.43% |
| Q4 2019 Q2Q % growth | -0.16 | -1.39 | 1.23 | 88.47% |
| Q3 2019 Q2Q % growth | 0.96 | -3.05 | 4.01 | 131.51% |
| Q2 2019 Q2Q % growth | -5.28 | -6.94 | 1.66 | 23.88% |
| Q1 2019 Q2Q % growth | -7.36 | -7.51 | 0.15 | 1.96% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 20.401M 495.65% | 17.297M | 3.104M | 17.95% |
| Q4 2024 Q2Q % growth | 12.043M -8.88% | 9.104M | 2.939M | 32.28% |
| Q3 2024 Q2Q % growth | 3.695M 27.63% | 4.966M | -1.271M | -25.59% |
| Q2 2024 Q2Q % growth | 4.449M -47.47% | 4.443M | 6K | 0.14% |
| Q1 2024 Q2Q % growth | 3.425M 18.96% | 3.839M | -414K | -10.78% |
| Q4 2023 Q2Q % growth | 13.217M 469.70% | 11.973M | 1.244M | 10.39% |
| Q3 2023 Q2Q % growth | 2.895M 0.87% | 3.447M | -552K | -16.01% |
| Q2 2023 Q2Q % growth | 8.47M 551.54% | 3.094M | 5.376M | 173.76% |
| Q1 2023 Q2Q % growth | 2.879M -27.48% | 2.708M | 171K | 6.31% |
| Q4 2022 Q2Q % growth | 2.32M -10.08% | 3.264M | -944K | -28.92% |
| Q3 2022 Q2Q % growth | 2.87M 45.69% | 3.264M | -394K | -12.07% |
| Q2 2022 Q2Q % growth | 1.3M -89.16% | 1.836M | -536K | -29.19% |
| Q1 2022 Q2Q % growth | 3.97M -67.24% | 3.126M | 844K | 27.00% |
| Q4 2021 Q2Q % growth | 2.58M 8.86% | 2.28M | 300K | 13.16% |
| Q3 2021 Q2Q % growth | 1.97M 2.07% | 2.228M | -258K | -11.58% |
| Q2 2021 Q2Q % growth | 11.99M 73.52% | 12.342M | -352K | -2.85% |
| Q1 2021 Q2Q % growth | 12.12M 479.90% | 2.142M | 9.978M | 465.83% |
| Q4 2020 Q2Q % growth | 2.37M 71.74% | 2.04M | 330K | 16.18% |
| Q3 2020 Q2Q % growth | 1.93M -83.16% | 1.938M | -8K | -0.41% |
| Q2 2020 Q2Q % growth | 6.91M | 6.885M | 25K | 0.36% |
| Q1 2020 Q2Q % growth | 2.09M | 5.916M | -3.826M | -64.67% |
| Q4 2019 Q2Q % growth | 1.38M | 5.66M | -4.28M | -75.62% |
| Q3 2019 Q2Q % growth | 11.46M | 2.992M | 8.468M | 283.02% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 33.2% | 129.26% | 0% | 450.88% |
| Revenue | 0.19% | 6.94% | 0% | 9.68% |